Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed it has enclosed the Press Release titled ‘SPARC Licenses Commercialization Rights of ElepsiaTM XR to Tripoint Therapeutics’ being released by the Company on 22nd September 2020, which is self-explanatory.
The above information is a part of company’s filings submitted to BSE.